Join the study
Did you receive a Key to Oregon invitation letter in the mail? If so, please consider enrolling today.
Already enrolled? Find your surveys
Please visit the enrollment page and click or tap “Sign in” or “My surveys.”
- You can request a thermometer.
- You can find surveys including a daily “Tell us how you feel today (1-5 minutes).”
Enter your email to receive updates on the Key to Oregon study:
See the Key to Oregon FAQ page to learn about:
- OHSU's commitment to ensure racial equity in the Key to Oregon study.
- Testing updates.
Study fact sheet
The Key to Oregon study will test, track and map the COVID-19 symptoms, and new infections, of up to 100,00 Oregonians in real time. Leaders will use the data to help keep Oregon open while protecting against new infections.
OHSU is working on the study in partnership with the OHSU-PSU School of Public Health and in collaboration with the Oregon Health Authority. Oregon Gov. Kate Brown announced the study May 1, 2020.
Why the study is important
The study will give researchers a better understanding of how many Oregonians are infected with the coronavirus, where infections are and how the virus spreads. Leaders expect the study to provide a science-based path to keeping Oregon open while protecting human health and lives.
“Just as Oregon was a national leader in slowing the initial spread of the virus, we have an opportunity to show the nation a sensible, systematic way to restore our economy.”
– OHSU President Danny Jacobs, M.D., M.P.H., FACS
Who will take part
Key to Oregon researchers randomly selected 150,000 Oregon households to receive invitations to join the study. Invitations were sent in the mail.
Researchers hope to enroll up to 100,000 adults in the study, which is expected to last up to one year. Taking part is voluntary. The study will follow strict OHSU research privacy guidelines.
Catching infections early
People in the study will report their temperature and any COVID-19 symptoms each day on our secure website. They will use their own thermometer or a “smart” thermometer that will be sent in the mail, one per household, at no cost if requested.
Those who have symptoms — as well as some randomly selected participants without symptoms — will receive a COVID-19 test kit at no cost.
The idea is to catch infections early, before they spread. Researchers also want to find infections in people who don’t feel sick so they get a true picture of the virus’s patterns.
Data will be tracked in real time, allowing the research team to see emerging hotspots early so officials can contain infections before new stay-home orders are needed. People who test positive for the coronavirus can stay home (isolate), and health officials can identify those they’ve come in contact with (contact tracing).
This study is not a substitute for health care. Anyone with symptoms of COVID-19 should contact a health care provider.
The state of Oregon has made an initial investment of $6 million to fund the study.
The research team
The Key to Oregon research team includes:
- OHSU President Danny Jacobs, M.D., M.P.H., FACS
- David Bangsberg, M.D., M.P.H., founding dean of the OHSU-PSU School of Public Health
- Brian Druker, M.D., director of the OHSU Knight Cancer Institute
- Principal investigators: Jackie Shannon, Ph.D., M.P.H., and Paul Spellman, Ph.D.
- The BIPOC (Black, Indigenous and People of Color) Scientific and Data Council, whose members include:
- Aileen Alfonso Duldulao, Ph.D., M.S.W., Multnomah County Health Department senior epidemiologist and research scientist
- Frank Franklin, Ph.D., J.D., M.P.H., Multnomah County Health Department principal epidemiologist and Epidemiology, Analytics and Evaluation Division director
- Kelly Gonzales, Ph.D., OHSU-PSU School of Public Health associate professor
- Zeenia Junker, N.D., Oregon Health Equity Alliance director
- Andres Lopez, Ph.D., M.A., Coalition of Communities of Color research director
- Phyusin MK Myint, Ph.D., M.P.P., Washington County Health and Human Services Department, Health Equity, Planning and Policy Program supervisor
- Tyler TerMeer, Ph.D., M.S., Cascade AIDS Project & Prism Health chief executive officer
- Consultants: OHSU Chair of Pathology Donna Hansel, Ph.D., M.D.; OHSU infectious disease experts; and researchers across OHSU, including from the Vaccine and Gene Therapy Institute